Verition Fund Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Verition Fund Management's RXRX Position: Q3 2026 in Review
Verition Fund Management held its Recursion Pharmaceuticals (RXRX) position steady in Q3 2026 at 446,947 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #1170.
Verition Fund Management first reported a position in RXRX in Q1 2023 and has held it in 8 quarters since. 354 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Verition Fund Management held 446,947 shares of Recursion Pharmaceuticals worth $1.85M as of Q3 2026.
- Verition Fund Management left its Recursion Pharmaceuticals share count unchanged in Q3 2026.
- Recursion Pharmaceuticals made up 0.01% of Verition Fund Management's portfolio in Q3 2026, its #1170 holding.
- Verition Fund Management first reported a position in Recursion Pharmaceuticals in Q1 2023 and has held it in 8 quarters since.
- 354 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.